AQR Capital Management
PROK icon

AQR Capital Management’s ProKidney PROK Stock Holding History

AQR Capital Management’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-198,338
Closed -$117K – 3559
2025
Q2 		$117K Buy
198,338
+145,768
+277% +$113K ﹤0.01% 3150
2025
Q1 		$46.1K Buy
52,570
+27,098
+106% +$37.6K ﹤0.01% 3085
2024
Q4 		$43K Buy
25,472
+8,099
+47% +$14.6K ﹤0.01% 2819
2024
Q3 		$33.4K Sell
17,373
-3,145
-15% -$7.14K ﹤0.01% 2726
2024
Q2 		$50.5K Buy
+20,518
New +$55.1K ﹤0.01% 2539

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management's PROK Position: Q3 2025 in Review

AQR Capital Management sold out of ProKidney (PROK) in Q3 2025, closing a stake of 198,338 shares — an estimated $117K sold.

AQR Capital Management first reported a position in PROK in Q2 2024 and held it in 5 quarters. The position peaked at $117K in Q2 2025. 56 funds tracked by Wall St. Rank hold PROK as of Q3 2025.

  • AQR Capital Management reported no remaining ProKidney position as of Q3 2025 after selling out during the quarter.
  • AQR Capital Management sold 198,338 ProKidney shares in Q3 2025, an estimated $117K.
  • AQR Capital Management first reported a position in ProKidney in Q2 2024 and held it in 5 quarters.
  • AQR Capital Management's ProKidney position peaked at $117K in Q2 2025.
  • 56 funds tracked by Wall St. Rank held ProKidney as of Q3 2025.

Based on AQR Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.